We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFCG
2676
AFC Gamma
AFCG
$60.9M
$195K ﹤0.01%
18,154
-105,232
-85% -$1.18M
CTV.WS
2677
CALL
DELISTED
Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
$194K ﹤0.01%
113,387
– –
BMEA icon
2678
Biomea Fusion
BMEA
$88.2M
$193K ﹤0.01%
+22,938
New +$196K
CINC
2679
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$191K ﹤0.01%
+15,538
New +$370K
ADV icon
2680
Advantage Solutions
ADV
$575M
$189K ﹤0.01%
3,640
-6,520
-64% -$410K
UIS icon
2681
Unisys
UIS
$252M
$185K ﹤0.01%
+36,280
New +$228K
INFU icon
2682
InfuSystem Holdings
INFU
$197M
$185K ﹤0.01%
21,260
-12,339
-37% -$101K
OMER icon
2683
Omeros
OMER
$845M
$181K ﹤0.01%
80,172
-41,771
-34% -$115K
DSKE
2684
DELISTED
Daseke, Inc. Common Stock
DSKE
$180K ﹤0.01%
31,600
-162,616
-84% -$960K
AOGO
2685
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$179K ﹤0.01%
17,678
– –
LGF.B
2686
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$177K ﹤0.01%
32,682
-18,498
-36% -$123K
CLOU icon
2687
Global X Cloud Computing ETF
CLOU
$236M
$175K ﹤0.01%
+10,900
New +$175K
CCO icon
2688
Clear Channel Outdoor Holdings
CCO
$1.22B
$172K ﹤0.01%
+163,670
New +$206K
AEVAW
2689
CALL
DELISTED
Aeva Technologies Warrants
AEVAW
$171K ﹤0.01%
125,569
-44,431
-26% -$10.4K
CNCE
2690
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$170K ﹤0.01%
+29,030
New +$153K
BSAC icon
2691
Banco Santander Chile
BSAC
$16.1B
$168K ﹤0.01%
+10,600
New +$158K
PVL
2692
Permianville Royalty Trust
PVL
$55.8M
$165K ﹤0.01%
49,276
-10,374
-17% -$36.5K
FOCL
2693
EDAP TMS S.A.
FOCL
$234M
$164K ﹤0.01%
+15,420
New +$151K
MTAL
2694
DELISTED
Metals Acquisition
MTAL
$163K ﹤0.01%
16,323
– –
GPUS
2695
Hyperscale Data Inc
GPUS
$52.9M
$163K ﹤0.01%
9
– –
ARAY icon
2696
Accuray
ARAY
$27.5M
$162K ﹤0.01%
+77,561
New +$160K
CCAP icon
2697
Crescent Capital BDC
CCAP
$405M
$161K ﹤0.01%
+12,636
New +$171K
RDFN
2698
DELISTED
Redfin
RDFN
$160K ﹤0.01%
+37,732
New +$177K
WHF icon
2699
WhiteHorse Finance
WHF
$138M
$159K ﹤0.01%
+12,167
New +$154K
TSHA icon
2700
Taysha Gene Therapies
TSHA
$1.61B
$157K ﹤0.01%
+69,296
New +$140K
106 107
108
109 110

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.